This trial will test a new suicide prevention intervention called LifePlans. It will be given to patients who have been admitted to a psychiatric hospital for suicidal thoughts and behaviors. The trial will assess the feasibility and acceptability of the intervention.
1 Primary · 1 Secondary · Reporting Duration: 1 Month
Active Control
Experimental Treatment
40 Total Participants · 2 Treatment Groups
Primary Treatment: LifePlans · No Placebo Group · N/A
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: